Serotonin and valvular heart disease

Helge Waldum; Rune Wiseth; Alexander Wahba

doi:10.1080/14728222.2022.2158082

Serotonin and valvular heart disease

Expert Opin Ther Targets. 2022 Oct;26(10):823-826. doi: 10.1080/14728222.2022.2158082. Epub 2022 Dec 15.

Authors

Helge Waldum¹, Rune Wiseth^{2

3}, Alexander Wahba^{3

4}

Affiliations

¹ Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
² Clinic of Cardiology, St Olav's University Hospital, Trondheim, Norway.
³ Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.
⁴ Clinic of Cardio-Thoracic Surgery, St Olav's University Hospital, Trondheim, Norway.

PMID: 36514958
DOI: 10.1080/14728222.2022.2158082

No abstract available

Keywords: 5-hydroxytryptamine receptor; Bicuspid aortic valve; platelets; pulmonal hypertension; rheumatic heart disease; serotonin; serotonin in blood; serotonin receptor; serotonin release; valvular heart disease.

Publication types

Editorial

MeSH terms

Aortic Valve
Heart Valve Diseases* / drug therapy
Humans
Serotonin*

Substances

Serotonin